Internet Program for Physical Activity and Exercise Capacity in Children With Juvenile Idiopathic Arthritis: A Multicenter Randomized Controlled Trial
Wineke Armbrust, Otto T. H. M. Lelieveld(University Medical Center Groningen), G. J. F. Joyce Bos(University Medical Center Groningen), Jeannette Cappon(Reade), Nico Wulffraat(Utrecht University), G. Elizabeth Legger(University Medical Center Groningen), Jan H. B. Geertzen(University Medical Center Groningen), Pieter J. J. Sauer(University of Groningen), Marco van Brussel(University Medical Center Utrecht), Marion A. J. van Rossum(Reade), Pieter U. Dijkstra(Siriraj Hospital)
Cited by 34
Related Papers
Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome
|Nature Genetics|2000|951
Anakinra as first‐line disease‐modifying therapy in systemic juvenile idiopathic arthritis: Report of forty‐six patients from an international multicenter series
|Arthritis & Rheumatism|2010|465
Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register
|Annals of the Rheumatic Diseases|2008|220
Sulfasalazine in the treatment of juvenile chronic arthritis: A randomized, double-blind, placebo-controlled, multicenter study
|Arthritis & Rheumatism|1998|217
Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study
|The Lancet Child & Adolescent Health|2019|214